Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort
Introduction
In 1948 the World Health Organization (WHO) defined health as not only the absence of disease, but also the presence of physical, mental and social well being (WHO, 1948). Subsequently, most branches of medicine began systematically assessing patients' subjective views of illness and symptoms, leading to the emergence of the construct of quality of life (QoL) as a promising clinical domain (Testa and Simonson, 1996). While there is still debate as to the definition of this construct and what it encompasses (Awad and Voruganti, 2012), indicators of QoL routinely include satisfaction with life/happiness (SWL), subjective evaluations of specific living conditions and objective assessments of functioning (Gladis et al., 1999).
QoL measurements are now an important aspect of the evaluation of the treatments and care provided to patients with schizophrenia (SZ) (Boyer et al., 2013a). QoL encompasses several important dimensions for patients and their families, such as psychological status, functional abilities, personal well-being, social interaction, economic status, vocational status, and physical health (Cramer et al., 2000). The use of QoL measures may provide information to clinicians regarding the general health status of their patients that might otherwise go unrecognized, thereby improving patient satisfaction and health outcomes (Boyer et al., 2013b). The knowledge of the factors that are determinants of QoL in SZ patients may assist clinicians in tailoring the most appropriate and effective interventions. However, the determinants of QoL remain poorly understood in this population.
Over recent decades, numerous studies have investigated the utility of psychotic symptoms, depression and functioning as predictors of QoL (Boyer et al., 2012, Fervaha et al., 2013, Meesters et al., 2013). Despite conflicting results due to the heterogeneity of study designs, selected characteristics, the sample examined, and the manner in which QoL has been defined and measured, general trends have emerged. A meta-analysis revealed that the strongest association was found between QoL and depression, outweighing the QoL effects of psychotic symptoms (Eack and Newhill, 2007) However, measures of functioning have been only moderately associated with QoL (Auquier et al., 2013). Importantly, six clinical predictors (including depression), explained only 20% of the QoL variance in a recent study (Fervaha et al., 2013), underscoring the need to better identify other factors that more adequately describe QoL in SZ patients.
Childhood maltreatment is a strong independent risk factor for suicidal attempts in SZ (Hassan et al., 2016), possibly aggravated by the development of depressive symptoms and feeling of hopelessness in adult life. From a biological point of view, history of childhood neglect has been found to predict disorganization in schizophrenia through grey matter decrease in dorsolateral cortex (Cancel et al., 2015). SZ patients with a history of childhood trauma may benefit from specific targeted therapies, such as cognitive behavioral therapy, which is commonly used in the management of SZ, although not always with significant efficacy in the treatment of trauma in SZ (Steel et al., 2016). It may therefore be hypothesized that history of childhood trauma may directly impact the QoL of patients with SZ. However, the association between childhood trauma and QoL in adults with SZ has not been explored to date.
The aims of the present study were (i) to determine the prevalence of a history of childhood trauma in a large non-selected multicentric sample of community-dwelling SZ patients (ii) to determine whether a history of childhood trauma was associated with impaired QoL and/or depression in adult SZ.
Section snippets
Design
The FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) cohort is based on a French national network of 10 Schizophrenia Expert Centers (Bordeaux, Clermont-Ferrand, Colombes, Créteil, Grenoble, Lyon, Marseille, Montpellier, Strasbourg, Versailles), set up by a French scientific cooperation foundation, FondaMental Foundation (www.fondation-fondamental.org) and created by the French Ministry of Research in order to build a platform that links systematic clinical assessment to
Results
A sample of 544 community-dwelling stable SZ patients enrolled in FACE-SZ cohort were included in this study. Table 1 shows demographic, clinical, functioning and treatment characteristics of the sample, as well as self-reported mean QoL levels. The majority of the patients in the sample (74.1%) were men and the mean age of the patients was 32.3 ± 9.8 years. The mean age at SZ onset was 21.6 years, the mean duration of illness was 10.6 years and the mean PANSS total score was 71 ± 19. No association
Discussion
The major results of this study may be summarized as follows: in a large multi-center sample of community-dwelling SZ patients, impaired QoL was independently associated with history of childhood trauma, current major depression and negative symptoms. Current major depression had the strongest association, however childhood trauma had both a significant direct and indirect association with impaired QoL, with the indirect association mediated via depression.
The association between history of
Contributors
The FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group*.
aFondation FondaMental, Créteil, France.
bCentre Hospitalier Charles Perrens, F-33076 Bordeaux, France; Université de Bordeaux ; CNRS UMR 5287-INCIA.
cHôpitaux Universitaires de Strasbourg, Université de Strasbourg, INSERM U1114, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France
dPôle de Psychiatrie et d'addictologie des Hôpitaux Universitaires H Mondor,INSERM U955, Eq. 15 Psychiatrie Génétique
Role of funding sources
No funding.
Conflicts of interest
None declared.
References (34)
- et al.
Reliability and validity of a depression rating scale for schizophrenics
Schizophr. Res.
(1992) - et al.
Predicting personality pathology among adult patients with substance use disorders: Effects of childhood maltreatment
Addict. Behav.
(1998) - et al.
Prevalence of self-reported childhood abuse in psychosis: a meta-analysis of retrospective studies
Psychiatry Res.
(2013) - et al.
The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia
Schizophr. Res
(2010) - et al.
Insight into illness, neurocognition and quality of life in schizophrenia
Prog. Neuropsychopharmacol. Biol. Psychiatry
(2012) - et al.
Association of metabolic syndrome and inflammation with neurocognition in patients with schizophrenia
Psychiatry Res.
(2013) - et al.
Amotivation and functional outcomes in early schizophrenia
Psychiatry Res.
(2013) - et al.
Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set
J. Affect. Disord.
(2016) - et al.
Childhood maltreatment increases the risk of suicide attempt in schizophrenia
Schizophr. Res.
(2016) - et al.
Subjective quality of life and its determinants in a catchment area based population of elderly schizophrenia patients
Schizophr. Res.
(2013)
Childhood sexual and physical abuse: age at exposure modulates impact on functional outcome in early psychosis patients
Psychol. Med.
Toward meeting the needs of homeless people with schizophrenia: the validity of quality of life measurement
PLoS One
Measuring quality of life in patients with schizophrenia: an update
PharmacoEconomics
Comparison of stopping rules in forward “stepwise” regression
J. Am. Stat. Assoc.
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.
Schizophr. Res
Measuring quality of life in patients with schizophrenia:an overview
Expert Rev. Pharmacoecon. Outcomes Res.
Purposeful selection of variables in logistic regression
Source Code Biol. Med.
Cited by (49)
Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studies
2024, Brain, Behavior, and ImmunityThe significant mediators between depression and mental health recovery among community-dwelling people with a diagnosed mental disorder
2022, Archives of Psychiatric NursingValidation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia
2022, Revista de Psiquiatria y Salud MentalCitation Excerpt :However, significant associations were found with physical and emotional functioning; these results are consistent with the literature, where negative symptoms and quality of life were negatively related.24 Even Andrianarisoa et al.25 found that psychotic symptoms do not have the same impact on the quality of life, where negative symptoms generated an affectation in more areas compared to positive symptoms. In spite of the different sources of ratings, we were able to demonstrate that the SNS (patient-rated) has a good discriminant validity to identify the different levels of severity rated by clinicians (CGI-SCH negative subscale).
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohort
2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry